Alexandra Dambeck has decided to step down from her role as Chief Financial Officer of Springer Nature and as a member of the Management Board to pursue a new external opportunity. Her specific end date in the fourth quarter of 2026 will be confirmed in due course, and she will remain in her role until that time. The process of selecting and appointing a successor is already underway, ensuring continuity in the company's financial leadership.
Frank Vrancken Peeters, CEO of Springer Nature, expressed appreciation for Dambeck's contributions, stating he had very much enjoyed working with her and would like to thank her for her commitment, professionalism, and dedication throughout her time at the company, including during its successful initial public offering. He wished her the very best in her future endeavors. Stefan von Holtzbrinck, Chair of the Supervisory Board, added his thanks and gratitude to Dambeck for all she achieved during her tenure, noting that she leaves the company in a strong financial position and set up for future growth.
Springer Nature is one of the leading publishers of research in the world, publishing the largest number of journals and books and serving as a pioneer in open research. Through its leading brands, trusted for more than 180 years, it provides technology-enabled products, platforms, and services that help researchers uncover new ideas and share their discoveries, health professionals stay at the forefront of medical science, and educators advance learning. For more information, please visit about.springernature.com. The original release can be viewed on www.newmediawire.com.
